Protective and Arthritis-Resolving Activity in Sera of Mice Infected with Borrelia burgdorferi.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S9
- By:
- Publication type:
- Article
Works matching IS 10584838 AND DT 1997 AND VI 25 AND IP Supplement_1
Results: 13
1
2
Specific Issues in the Design and Implementation of an Efficacy Trial for a Lyme Disease Vaccine.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S71
- By:
- Publication type:
- Article
3
Why Is Chronic Lyme Borreliosis Chronic?
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S64
- By:
- Publication type:
- Article
4
Functional Brain Imaging and Neuropsychological Testing in Lyme Disease.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S57
- By:
- Publication type:
- Article
5
Activity of Sera from Patients with Lyme Disease Against Borrelia burgdorferi.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S25
- By:
- Publication type:
- Article
6
Tetracycline Therapy for Chronic Lyme Disease.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S52
- By:
- Publication type:
- Article
7
Is Human Granulocytic Ehrlichiosis a New Lyme Disease? Review and Comparison of Clinical, Laboratory, Epidemiological, and Some Biological Features.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S43
- By:
- Publication type:
- Article
8
The Cold Zone: A Curious Convergence of Tick-Transmitted Diseases.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S35
- By:
- Publication type:
- Article
9
The Western Immunoblot for Lyme Disease: Determination of Sensitivity, Specificity, and Interpretive Criteria with Use of Commercially Available Performance Panels.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S31
- By:
- Publication type:
- Article
10
Invasion and Cytopathic Killing of Human Lymphocytes by Spirochetes Causing Lyme Disease.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S2
- By:
- Publication type:
- Article
11
The Antimicrobial Agent Melittin Exhibits Powerful In Vitro Inhibitory Effects on the Lyme Disease Spirochete.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S48
- By:
- Publication type:
- Article
12
Pathological Manifestations in Murine Lyme Disease: Association with Tissue Invasion and Spirochete Persistence.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S18
- By:
- Publication type:
- Article
13
Introduction.
- Published in:
- Clinical Infectious Diseases, 1997, v. 25, n. Supplement_1, p. S1
- By:
- Publication type:
- Article